NORTHBROOK, IL--(Marketwired - Jul 24, 2013) - Nanosphere, Inc. (
Conference Call & Webcast Tuesday, August 6, 2013 @ 5:00pm Eastern/2:00pm Pacific Domestic: 888-713-4205 International: 617-213-4862 Passcode: 74181181 Webcast: www.nanosphere.us Pre-Registration: https://www.theconferencingservice.com/prereg...=P9XTLQNCG
Replays - Available through August 14, 2013 Domestic: 888-286-8010 International: 617-801-6888 Passcode: 27570830
About Nanosphere, Inc. Nanosphere develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene® System, for multiplexed infectious disease, genetic and ultra-sensitive protein testing. This easy-to-use platform offers laboratories a convenient, simple and cost-effective solution for highly sensitive nucleic acid and protein testing. Nanosphere is based in Northbrook, IL.
For additional information regarding Nanosphere's infectious disease products, please contact Nanosphere at IDtesting@nanosphere.us or visit www.nanosphere.us .
Forward Looking Statement - Except for historical information, the matters discussed in this press release are "forward-looking statements" and are subject to risks and uncertainties. Actual results could differ materially from these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the following: (i) Nanosphere's ability to develop commercially viable products; (ii) Nanosphere's ability to achieve profitability; (iii) Nanosphere's ability to produce and market its products; (iv) Nanosphere's ability to obtain regulatory approval of its products; (v) Nanosphere's ability to protect its intellectual property; (vi) competition and alternative technologies; and (vii) Nanosphere's ability to obtain additional financing to support its operations. Additional risks are discussed in the Company's current filings with the Securities and Exchange Commission. Although the Company believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. The forward-looking statements are made as of the date of this press release, and we undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Contacts Investors: Roger Moody Chief Financial Officer Nanosphere, Inc. 847-400-9021 rmoody@nanosphere.us Media: Lindsey Saxon Director of Communications Nanosphere, Inc. 847-400-9173 lsaxon@nanosphere.us
